Company

CeraVx

Pharmaceutical Manufacturing Nl 9 employees

Employees: 9
Contacts: 3
Emails: 3

mylifetechnologies.nl LinkedIn

CeraVx Overview

Headquarters: Nl
Website: mylifetechnologies.nl
Industry: Pharmaceutical Manufacturing
Employees: 9
Founded: 2024
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

dermal drug delivery vaccine delivery mRNA nano particles Therapeutic vaccines infectious diseases prophylactic vaccines Skin patches Leiden Bio Science Park

About CeraVx

CeraVx B.V. is a privately held global biotechnology company developing and commercializing a proprietary drug delivery platform based on a ceramic micro-needle array patches (CeraMAPs™). The CeraMaps technology was initially developed at the University of Twente, MESA+, Institute for Nanotechnology, The Netherlands. The company is focussing on prophylactic and therapeutic vaccines. In 2024 CeraVx acquired the propietary micro-needle technology from MLT.

CeraVx Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

CeraVx Org Chart

Sample employees and titles

Name	Title	Location	Contact
Koen Van Der Maaden	Assistant Professor (Tenure Track) at Leiden University Medical Centre (Lumc)	Leiden, South Holland, Netherlands	Email
Dinja Oosterhoff	Senior Vaccine Development Executive - Cso Praetorian Bio - Managing Partner Bactheravax	Almere, Flevoland, Netherlands	Email
Francesca Tana		Leiden, South Holland, Netherlands	Email
Dr. Jan Groen	Chairman of the Board at Angle Plc (Life Science Executive)		View